Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • Breakthrough Candidemia in Patients with Cancer Differs from De Novo Candidemia in Host Factors and Candida Species But Not Intensity

  • Dimitrios P. Kontoyiannis, Bhavanandra T. Reddy, Hend Hanna, Gerald P. Bodey, Jeffrey Tarrand, Issam I. Raad
  • Journal:
    Infection Control & Hospital Epidemiology / Volume 23 / Issue 9 / September 2002
    Published online by Cambridge University Press:
    02 January 2015, pp. 542-545
    Print publication:
    September 2002
  • Objectives:

    To evaluate the risk factors associated with breakthrough candidemia in patients with cancer and to compare them with those of de novo candidemia in this patient population. DESIGN: Retrospective case series of 120 episodes of candidemia, 90 de novo and 30 breakthrough candidemias.

    Setting:

    University-affiliated, tertiary-care cancer center in Houston, Texas.

    Patients:

    All patients with cancer who acquired candidemia between January 1993 and December 1998 were included if they had non-catheter-related candidemia and information about quantitative blood cultures.

    Results:

    Although less frequent, breakthrough candidemia was seen more often in neutropenic patients with leukemia. The intensity of breakthrough candidemia was comparable to that of de novo candidemia. Most (70%) of the breakthrough candidemias were due to Candida glabrata or C. krusei.

    Conclusions:

    In breakthrough candidemia, the same risk factors seen in de novo candidemia were encountered, although more frequently. C. glabrata and C. krusei are the leading causes of breakthrough candidemia in patients with cancer.